News

Intelligensys and InhibOx Apply Proven Formulation Approaches to Improve Lead Discovery Efficiency

Submitted by InhibOx on February 8, 2010 - 16:00

Oxford and Stokesley, UK — 8th February 2010

InhibOx Ltd (Oxford, UK) and Intelligensys Ltd (Stokesley, North Yorkshire, UK) announce a partnership to apply advanced machine learning approaches, already successful in formulation design, to improve virtual screening and computer-aided drug design (CADD) efficiency.

InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery

Submitted by InhibOx on December 3, 2009 - 16:00

Oxford, UK — 3rd December 2009

InhibOx Ltd (Oxford, UK) and MolPort Ltd (Riga, Latvia) announce a strategic partnership to deliver integration in library design and compound provision.

Prof. W. Graham Richards discusses his latest book, “Spin-Outs”

Submitted by InhibOx on November 19, 2009 - 16:00

Oxford, UK - September 2009

Prof. W Graham Richard discusses his latest book, “Spin-Outs: Creating Businesses from University Intellectual Property”. In it, Prof. Richards describes his experiences in launching a spin-out, carefully signposting the path from intellectual property to a start-up company, to flotation on the stock market.

InhibOx Announces Important Breakthrough in Molecular Similarity: Chiral Shape Recognition (CSR)

Submitted by InhibOx on November 15, 2009 - 16:00

Oxford, UK - November 2009

The quantitative measurement of molecular similarity has long been an essential tool in computer-aided drug discovery, in particular for the identification of new leads and scaffold hopping. Until now, however, there has been no fast, non-superpositional method that accounts for enantiomeric (mirror image) molecules, an essential facet of many biological interactions. InhibOx has now made an important breakthrough to meet this challenge.

Successful DrugFinder Collaboration with Oxford University Chemistry Department Discovers Novel Kinase Inhibitors

Submitted by InhibOx on November 9, 2009 - 16:00

Oxford, UK - November 2009

As part of its DrugFinder initiative, InhibOx has undertaken a project in collaboration with the group of Dr. Angela Russell of the Chemistry Department, at the University of Oxford.  Taking an oncology kinase target as its starting point, InhibOx performed virtual screening of its internal databases, using its proprietary software platform to identify potential inhibitors for experimental screening.

InhibOx presents at 8th International Symposium on Carbonic Anhydrases: “Computational Approaches to the Design of New Carbonic Anhdydrase Inhibitors”

Submitted by InhibOx on September 17, 2009 - 09:00

Oxford, UK - September 2009

InhibOx presents at ELRIG Drug Discovery 2009: “Harnessing Modern Web Technologies for Virtual Screening.”

Submitted by InhibOx on September 7, 2009 - 16:00

Oxford, UK - September 2009